CureVac N.V. (CVAC)
USD 3.56
(4.71%)
USD 3.56
(4.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -70.6 Million EUR | 21.87% |
| 2022 | -116.57 Million EUR | 13.78% |
| 2021 | -135.2 Million EUR | -489.34% |
| 2020 | 34.72 Million EUR | 428.64% |
| 2019 | -10.56 Million EUR | -116.85% |
| 2018 | -4.87 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -31.22 Million EUR | 10.33% |
| 2024 Q1 | -29.31 Million EUR | 22.39% |
| 2023 Q1 | -13.5 Million EUR | 80.23% |
| 2023 FY | -91.07 Million EUR | 21.87% |
| 2023 Q4 | -37.77 Million EUR | -384.42% |
| 2023 Q3 | -7.79 Million EUR | 57.33% |
| 2023 Q2 | -18.27 Million EUR | -35.31% |
| 2022 Q3 | -12.86 Million EUR | 42.9% |
| 2022 Q2 | -22.53 Million EUR | -75.25% |
| 2022 Q1 | -12.85 Million EUR | 55.34% |
| 2022 FY | -116.57 Million EUR | 13.78% |
| 2022 Q4 | -68.31 Million EUR | -430.91% |
| 2021 Q2 | -15 Million EUR | -161.8% |
| 2021 Q4 | -28.79 Million EUR | 66.4% |
| 2021 Q3 | -85.68 Million EUR | -471.17% |
| 2021 Q1 | -5.73 Million EUR | -409.79% |
| 2021 FY | -135.2 Million EUR | -489.34% |
| 2020 Q4 | -1.12 Million EUR | -135.25% |
| 2020 FY | 34.72 Million EUR | 428.64% |
| 2020 Q1 | -2.35 Million EUR | -2.66% |
| 2020 Q3 | 3.18 Million EUR | -90.66% |
| 2020 Q2 | 34.15 Million EUR | 1549.49% |
| 2019 Q4 | -2.29 Million EUR | 61.12% |
| 2019 Q1 | -4.4 Million EUR | 0.0% |
| 2019 FY | -10.56 Million EUR | -116.85% |
| 2019 Q3 | -5.9 Million EUR | 0.0% |
| 2018 FY | -4.87 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -72691.753% |
| Psyence Biomedical Ltd. | -240.00 USD | -29419900.0% |
| XOMA Corporation | 3.86 Million USD | 1928.749% |
| Mesoblast Limited | -9.81 Million USD | -619.389% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 152.198% |
| Aptorum Group Limited | -1.11 Million USD | -6234.329% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1570712.013% |
| HilleVax, Inc. | -2.15 Million USD | -3174.954% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -894.759% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -126.543% |
| Precision BioSciences, Inc. | 40.47 Million USD | 274.461% |
| Dyadic International, Inc. | 922.95 Thousand USD | 7750.194% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -47932.653% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 33.466% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 435.255% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 16752.83% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 270.608% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 174.542% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -712.801% |
| IGM Biosciences, Inc. | -211.66 Million USD | 66.641% |
| Opthea Limited | 21.72 Thousand USD | 325182.873% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 17664.179% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 2999.713% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2432.607% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 158.961% |
| NextCure, Inc. | -3.68 Million USD | -1816.612% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -428.588% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -5760.169% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 452.124% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 145.615% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 28.11% |
| Senti Biosciences, Inc. | -2.68 Million USD | -2531.681% |
| Apollomics, Inc. | 127 Thousand USD | 55696.85% |
| PureTech Health plc | -1.6 Million USD | -4304.741% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -143.745% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 8903.99% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 36.095% |
| ChromaDex Corporation | 50.78 Million USD | 239.047% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 158.608% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -55.782% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1027.923% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 28.071% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 58940.0% |
| Fortress Biotech, Inc. | 57.85 Million USD | 222.047% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -62.455% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -306891.304% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 54413.846% |
| Celcuity Inc. | -142.77 Thousand USD | -49355.075% |
| ContextLogic Inc. | 59 Million USD | 219.675% |
| GH Research PLC | -315 Thousand USD | -22315.238% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 525.94% |
| Cassava Sciences, Inc. | -89.42 Million USD | 21.04% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 18251.157% |
| ImmuCell Corporation | 4.39 Million USD | 1706.084% |
| Amarin Corporation plc | 165.54 Million USD | 142.653% |
| TG Therapeutics, Inc. | 219.1 Million USD | 132.225% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -3437.475% |
| Acelyrin, Inc. | -115 Thousand USD | -61298.261% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 1104.81% |
| Novavax, Inc. | 639.93 Million USD | 111.034% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 13810.291% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.078% |
| AnaptysBio, Inc. | 14.78 Million USD | 577.694% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -12352.91% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -5517.184% |
| AbCellera Biologics Inc. | 38.02 Million USD | 285.688% |
| CorMedix Inc. | -205.56 Thousand USD | -34248.761% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 388.773% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -893.687% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.625% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -14779.095% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -678823.077% |
| Soligenix, Inc. | 97.31 Thousand USD | 72659.115% |
| Century Therapeutics, Inc. | -10.8 Million USD | -553.233% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 129.33% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -13563.966% |
| Kura Oncology, Inc. | -849 Thousand USD | -8216.608% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1888.398% |
| Ardelyx, Inc. | 106.66 Million USD | 166.199% |
| Ainos, Inc. | -253.73 Thousand USD | -27727.677% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -5.222% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| Prothena Corporation plc | -129.2 Million USD | 45.35% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 171.293% |
| Autolus Therapeutics plc | -4.86 Million USD | -1350.75% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 240.029% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -41928.571% |
| Celularity Inc. | 6.75 Million USD | 1145.27% |
| Rallybio Corporation | -150 Thousand USD | -46972.0% |
| GRI Bio, Inc. | 10.84 Million USD | 751.305% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 2879.858% |
| Omeros Corporation | -69.77 Million USD | -1.188% |
| INmune Bio, Inc. | 155 Thousand USD | 45653.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 213.996% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4587.54% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -10788.668% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -241096.967% |
| Humacyte, Inc. | -76.55 Million USD | 7.762% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -22458.466% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 174.748% |
| Immunocore Holdings plc | 248.39 Million USD | 128.426% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -365.476% |
| Verastem, Inc. | -62 Thousand USD | -113783.871% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -26952.874% |
| Histogen Inc. | 3.76 Million USD | 1973.388% |
| Surrozen, Inc. | -27.23 Million USD | -159.302% |
| Blueprint Medicines Corporation | 236.58 Million USD | 129.845% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1210.225% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| IO Biotech, Inc. | -756 Thousand USD | -9239.683% |
| MEI Pharma, Inc. | 49.32 Million USD | 243.143% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1263.915% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -105079.425% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -4851.473% |
| Summit Therapeutics Inc. | -2.05 Million USD | -3344.293% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1371.613% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 343.015% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 48527.984% |
| Turnstone Biologics Corp. | 16.5 Million USD | 527.772% |
| Pulmatrix, Inc. | -8.22 Million USD | -758.978% |
| Synaptogenix, Inc. | -6347.00 USD | -1112362.581% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -138347.059% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 143.757% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -17596.241% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 82.295% |
| Cytokinetics, Incorporated | -322.59 Million USD | 78.112% |
| Exelixis, Inc. | 1.75 Billion USD | 104.017% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 37.048% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 120.885% |
| Evogene Ltd. | 1.39 Million USD | 5147.034% |
| Replimune Group, Inc. | -2.65 Million USD | -2559.435% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -123069.243% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -6272.563% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -59489.336% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | 6472.563% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1064.854% |
| Insmed Incorporated | 239.63 Million USD | 129.465% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 14335.484% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -4983.369% |
| Sagimet Biosciences Inc. | 2 Million USD | 3630.4% |
| MediWound Ltd. | 3.57 Million USD | 2073.393% |
| MiMedx Group, Inc. | 266.84 Million USD | 126.461% |
| OmniAb, Inc. | 14.66 Million USD | 581.407% |
| Alector, Inc. | -95.05 Million USD | 25.717% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 156.207% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 108.094% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1050.821% |
| Zai Lab Limited | 170.9 Million USD | 141.315% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 186.237% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -588300.0% |
| Aura Biosciences, Inc. | -1.29 Million USD | -5352.355% |
| Immunic, Inc. | -111 Thousand USD | -63510.811% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -2769.078% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 545.364% |
| Veracyte, Inc. | 248.14 Million USD | 128.454% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.99% |
| FibroGen, Inc. | 128.9 Million USD | 154.776% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Allakos Inc. | -6.14 Million USD | -1049.78% |
| scPharmaceuticals Inc. | 9.78 Million USD | 821.816% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -2.336% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 114.837% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -12519048.936% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -618834.081% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -505.2% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 119.87% |
| Precigen, Inc. | 106 Thousand USD | 66711.321% |
| Fortrea Holdings Inc. | 424 Million USD | 116.653% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 18.057% |
| Incyte Corporation | 3.44 Billion USD | 102.052% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -139056.484% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 577.275% |
| XBiotech Inc. | -1.74 Million USD | -3948.624% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 666.677% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -6272.563% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 129.303% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -243375.862% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -51.94% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 6.522% |
| Agenus Inc. | 139.61 Million USD | 150.573% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1653.349% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 196.192% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 520.211% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 118.149% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -42.22% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 36363.533% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 121.609% |
| UroGen Pharma Ltd. | 73.35 Million USD | 196.259% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -523.534% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -164.509% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1307655.556% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -37258.73% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -105557.893% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1842.977% |
| Chimerix, Inc. | 324 Thousand USD | 21892.593% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -13349.143% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -159689.988% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -31852.647% |
| Pluri Inc. | 322 Thousand USD | 22027.95% |
| Cue Biopharma, Inc. | -32.6 Million USD | -116.542% |
| MeiraGTx Holdings plc | 287 Thousand USD | 24702.091% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 12354.525% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -3565960.606% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 213.186% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -576.001% |
| CalciMedica, Inc. | -58 Thousand USD | -121637.931% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2382.7% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -128.764% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -5934.872% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -618834.081% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2643.896% |
| Nutriband Inc. | 862.1 Thousand USD | 8290.186% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -20606.158% |
| Vor Biopharma Inc. | -3.49 Million USD | -1921.993% |
| Roivant Sciences Ltd. | 109.23 Million USD | 164.639% |
| ProKidney Corp. | -3.16 Million USD | -2128.085% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -60.794% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2649.465% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1129.721% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -3983.748% |
| Bicycle Therapeutics plc | -129.52 Million USD | 45.485% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 10.249% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -213863.636% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 82.333% |
| Atai Life Sciences N.V. | -5000.00 USD | -1412060.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -57842.376% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -73450.0% |
| MediciNova, Inc. | 979.7 Thousand USD | 7307.067% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 16.261% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -74573.999% |
| GeoVax Labs, Inc. | -20.72 Million USD | -240.76% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 224.555% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 128.874% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1580.743% |
| RenovoRx, Inc. | - USD | Infinity% |
| Erasca, Inc. | -3.73 Million USD | -1791.961% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -22676.774% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1412060.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 7.548% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 133.035% |
| bluebird bio, Inc. | -4.03 Million USD | -1652.06% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -7403.507% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 7097.82% |
| Imunon, Inc. | -720 Thousand USD | -9706.599% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 103.708% |
| BioAtla, Inc. | -103.73 Million USD | 31.932% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 70.922% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -22603.537% |
| DBV Technologies S.A. | 15.72 Million USD | 548.932% |
| Fortress Biotech, Inc. | 57.85 Million USD | 222.047% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 61.078% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -0.746% |
| aTyr Pharma, Inc. | -2.38 Million USD | -2856.784% |
| Viridian Therapeutics, Inc. | -1 Million USD | -6904.762% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 543138561.538% |
| Galecto, Inc. | -830 Thousand USD | -8406.988% |
| Akari Therapeutics, Plc | -4000.00 USD | -1765100.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 111.086% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 6409.92% |
| Entera Bio Ltd. | -56 Thousand USD | -125985.714% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 152.776% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -12265.674% |
| Xencor, Inc. | -85.26 Million USD | 17.185% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 2843.124% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -79.468% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -6952.084% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 139.702% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 36363.533% |
| Portage Biotech Inc. | -54 Thousand USD | -130655.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -74573.999% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -18628.912% |
| OncoCyte Corporation | 413 Thousand USD | 17196.368% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -31805305.405% |
| Purple Biotech Ltd. | -196 Thousand USD | -35924.49% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 887.333% |
| Onconetix, Inc. | -1.12 Million USD | -6164.212% |
| MacroGenics, Inc. | 50.52 Million USD | 239.743% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -470494.508% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -10470.06% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 470.782% |
| Prime Medicine, Inc. | -147.9 Million USD | 52.261% |
| Aditxt, Inc. | -111.66 Thousand USD | -63134.82% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -940567.399% |
| Savara Inc. | -44.26 Million USD | -59.523% |
| Curis, Inc. | 9.81 Million USD | 819.682% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -56482.364% |
| Adagene Inc. | 18.11 Million USD | 489.852% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -30868.421% |
| BeiGene, Ltd. | 2.07 Billion USD | 103.396% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 11694.089% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -49172.51% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 150.362% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -250123.262% |
| SciSparc Ltd. | 2.19 Million USD | 3315.301% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -250123.262% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -7616.721% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -281779.516% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -227800.071% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 981.939% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 229.274% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -13073.134% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 104.652% |
| ADMA Biologics, Inc. | 88.21 Million USD | 180.038% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 164.322% |
| Clene Inc. | 533 Thousand USD | 13347.28% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 36.462% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1867.893% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -7278.056% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 3651.71% |
| Adicet Bio, Inc. | -6.09 Million USD | -1057.888% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 241.769% |
| Absci Corporation | -41.84 Million USD | -68.721% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 14568.852% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 144.735% |
| Surrozen, Inc. | -27.23 Million USD | -159.302% |
| Generation Bio Co. | -73.91 Million USD | 4.469% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 9.008% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -16057.437% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -50.746% |
| Invivyd, Inc. | -2.02 Million USD | -3381.657% |
| Cingulate Inc. | -582.91 Thousand USD | -12012.853% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 76.53% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -68161.181% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -932634.478% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 173.269% |
| Jaguar Health, Inc. | 7.72 Million USD | 1014.138% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 171.838% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 997.065% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -7914.529% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 110.373% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 392.868% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -36236.689% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Kronos Bio, Inc. | 1.37 Million USD | 5246.356% |
| Innoviva, Inc. | 261.06 Million USD | 127.046% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -31.569% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 342.398% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -8345.933% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 184.647% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 96675.118% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 232.817% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 59.23% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -19902.266% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -227667.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -258.434% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -7046.559% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -125220.365% |
| AlloVir, Inc. | -398 Thousand USD | -17640.704% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -6741.86% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 122.51% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -24080.822% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -10533.735% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1859.482% |
| ImmunityBio, Inc. | -17.89 Million USD | -294.679% |
| Korro Bio, Inc. | -3.63 Million USD | -1845.124% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 27.171% |
| Kineta, Inc. | 5.43 Million USD | 1399.613% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -40283.658% |
| BioVie Inc. | -229.37 Thousand USD | -30682.511% |
| Codexis, Inc. | 57.33 Million USD | 223.152% |
| Celularity Inc. | 6.75 Million USD | 1145.27% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -18779.144% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 139669.085% |
| Kodiak Sciences Inc. | -25.94 Million USD | -172.124% |
| Cibus, Inc. | 1.42 Million USD | 5065.401% |
| Annexon, Inc. | -3.26 Million USD | -2061.249% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -69.174% |
| Moderna, Inc. | 2.15 Billion USD | 103.276% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 109.07% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -3354.403% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 11132.5% |
| Immix Biopharma, Inc. | -5468.00 USD | -1291194.806% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 140.824% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1034.812% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 167.828% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -3616.211% |
| Alkermes plc | 1.37 Billion USD | 105.136% |
| Arcellx, Inc. | 108.27 Million USD | 165.209% |
| Moolec Science SA | -143.3 Thousand USD | -49171.135% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -118.135% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2248.099% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 189.147% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -233.812% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -0.739% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -3635.873% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1954717.276% |
| Humacyte, Inc. | -76.55 Million USD | 7.762% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -66.851% |
| Geron Corporation | -123.5 Million USD | 42.829% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1712.791% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Royalty Pharma plc | 1.79 Billion USD | 103.936% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 30614.584% |
| Notable Labs, Ltd. | 113 Thousand USD | 62584.956% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 36.626% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -7338.889% |
| IN8bio, Inc. | -2.5 Million USD | -2723.191% |
| 89bio, Inc. | -273 Thousand USD | -25763.736% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -235260.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 3892.052% |
| Acasti Pharma Inc. | -11 Thousand USD | -641790.909% |
| Genelux Corporation | -848 Thousand USD | -8226.415% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -57304.878% |
| Liquidia Corporation | 14.6 Million USD | 583.616% |
| Mustang Bio, Inc. | -2.22 Million USD | -3073.393% |
| Immunovant, Inc. | -231 Thousand USD | -30466.234% |
| Vericel Corporation | 135.57 Million USD | 152.08% |
| Quantum-Si incorporated | 488 Thousand USD | 14568.852% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -27.087% |
| XOMA Corporation | 3.86 Million USD | 1928.749% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -252.406% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -34407.397% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -10788.668% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -6474.302% |
| Vaxcyte, Inc. | -75 Million USD | 5.856% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 57.849% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -18432.283% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -221.135% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 203.643% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -3506.129% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -8356.048% |
| PepGen Inc. | -1.18 Million USD | -5863.514% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -55496.85% |
| United Therapeutics Corporation | 2.07 Billion USD | 103.411% |
| Solid Biosciences Inc. | -76.56 Million USD | 7.778% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -85399.437% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | -9140.216% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 106655.596% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1691.15% |
| Belite Bio, Inc | -399 Thousand USD | -17596.241% |
| Pharming Group N.V. | 220.1 Million USD | 132.079% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bionomics Limited | -434.44 Thousand USD | -16152.31% |
| Pyxis Oncology, Inc. | -2 Million USD | -3430.4% |
| uniQure N.V. | 2.21 Million USD | 3287.72% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -86007.317% |
| GeoVax Labs, Inc. | -20.72 Million USD | -240.76% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 23.31% |
| Altimmune, Inc. | -65.37 Million USD | -8.008% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -6474.302% |
| Peak Bio, Inc. | 367.76 Thousand USD | 19299.008% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -16057.437% |
| Benitec Biopharma Inc. | 108 Thousand USD | 65477.778% |
| Zura Bio Limited | - USD | Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 119.503% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -702397.264% |
| Compugen Ltd. | 31.45 Million USD | 324.473% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 6323.272% |
| argenx SE | 1.1 Billion USD | 106.37% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 388.008% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -208.372% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -90423.077% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -5769.327% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -13298.102% |
| PolyPid Ltd. | -1.82 Million USD | -3775.302% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -59234.454% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1378.082% |
| Forte Biosciences, Inc. | -9000.00 USD | -784433.333% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 2957.467% |
| Instil Bio, Inc. | -4.75 Million USD | -1384.609% |
| Elevation Oncology, Inc. | -39 Thousand USD | -180946.154% |
| Immunome, Inc. | -8.9 Million USD | -692.725% |
| Verona Pharma plc | -679.62 Thousand USD | -10289.274% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -17204.61% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -40247.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | -2860.503% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -2833.444% |
| Design Therapeutics, Inc. | -537 Thousand USD | -13048.603% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -16435.831% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 3390.214% |
| Achilles Therapeutics plc | -4.73 Million USD | -1392.37% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 164304.651% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -8489.781% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -536516.507% |
| Beam Therapeutics Inc. | -59.67 Million USD | -18.327% |
| Moolec Science SA | -143.3 Thousand USD | -49171.135% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1412060.0% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 427.723% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -23673.737% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -638.114% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 601.477% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -2542.982% |
| Athira Pharma, Inc. | -969 Thousand USD | -7186.687% |
| HCW Biologics Inc. | -574.82 Thousand USD | -12183.412% |
| XOMA Corporation | 3.86 Million USD | 1928.749% |
| NeurAxis, Inc. | 2.15 Million USD | 3373.885% |
| Lumos Pharma, Inc. | 2 Million USD | 3618.087% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -40247.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -66716.182% |
| Nektar Therapeutics | 53.47 Million USD | 232.032% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -5769.327% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 323.028% |
| Arvinas, Inc. | 71.8 Million USD | 198.34% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Palisade Bio, Inc. | 246 Thousand USD | 28802.439% |
| Nutriband Inc. | 862.1 Thousand USD | 8290.186% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -55.019% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -213863.636% |
| Merus N.V. | -83.46 Million USD | 15.4% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -12.478% |
| Neurogene Inc. | -3.26 Million USD | -2064.562% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 150.675% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -128278.182% |
| CervoMed Inc. | -1.29 Million USD | -5358.142% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1812.459% |
| Sesen Bio, Inc. | 40 Million USD | 276.52% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -21827.95% |
| Rezolute, Inc. | -36 Thousand USD | -196033.333% |
| Clene Inc. | 533 Thousand USD | 13347.28% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -5498965.421% |
| BeyondSpring Inc. | 1.75 Million USD | 4132.439% |
| Synlogic, Inc. | -1.92 Million USD | -3569.854% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -190732.432% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1015.098% |
| Peak Bio, Inc. | 367.76 Thousand USD | 19299.008% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -272.346% |
| Krystal Biotech, Inc. | 47.6 Million USD | 248.321% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 150.044% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1505.134% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -2627.0% |
| MannKind Corporation | 136.19 Million USD | 151.845% |
| Ikena Oncology, Inc. | -50.49 Million USD | -39.84% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 164.889% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1510.217% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -27919.048% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1412060.0% |
| Legend Biotech Corporation | 140.92 Million USD | 150.102% |
| Mural Oncology plc | -2.56 Million USD | -2650.604% |
| Disc Medicine, Inc. | -100 Thousand USD | -70508.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 440.214% |
| REGENXBIO Inc. | 53.02 Million USD | 233.15% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1218.063% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -36603.314% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -3976.674% |
| Vaxart, Inc. | -60.76 Million USD | -16.202% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -26769.625% |
| Cellectis S.A. | 18 Thousand USD | 392366.667% |
| Longeveron Inc. | 221 Thousand USD | 32049.321% |
| Repare Therapeutics Inc. | -80.07 Million USD | 11.817% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 106.46% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -5356.569% |
| Revolution Medicines, Inc. | -399.66 Million USD | 82.333% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -201637.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 144197.959% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.82% |
| Denali Therapeutics Inc. | -93.34 Million USD | 24.358% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -281779.516% |
| Veru Inc. | 7.56 Million USD | 1033.236% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -46660.265% |
| Cingulate Inc. | -582.91 Thousand USD | -12012.853% |
| Passage Bio, Inc. | -3.72 Million USD | -1797.554% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -586150.415% |
| Exicure, Inc. | -1.42 Million USD | -4861.911% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -18335.509% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 2712.209% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -13672.468% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -47095.653% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -19.258% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 18158.312% |
| OmniAb, Inc. | 14.66 Million USD | 581.407% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 453.164% |
| Lipocine Inc. | -2.85 Million USD | -2376.763% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -3731.145% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1137.651% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4587.54% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 193.749% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -108527.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 183.762% |
| Ocugen, Inc. | -33.53 Million USD | -110.538% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2133.017% |
| Q32 Bio Inc. | 578 Thousand USD | 12315.917% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -26544.528% |
| Alumis Inc. Common Stock | -1.28 Million USD | -5399.065% |
| Equillium, Inc. | 35.95 Million USD | 296.362% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -4036.38% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 14202.449% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1707882.583% |
| Dominari Holdings Inc. | 2.03 Million USD | 3562.874% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -38384.556% |
| vTv Therapeutics Inc. | -13.59 Million USD | -419.367% |
| Bio-Techne Corporation | 773.07 Million USD | 109.133% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 507.691% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 115.323% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -5940.034% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -194.445% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 703.642% |
| Nkarta, Inc. | -5.86 Million USD | -1103.067% |
| BioCardia, Inc. | -7.24 Million USD | -874.038% |
| Iterum Therapeutics plc | -1.75 Million USD | -3934.743% |